← Eichor
Study identifier: NCT07423065 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Impact of Continuous Glucose Monitoring on Glucose Variability and Weight Loss in Individuals With Prediabetes and Obesity

Condition: Pre Diabetic · Obesity & Overweight  ·  Sponsor: University of Primorska

PhaseNA
Planned participants34
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

This randomized, crossover interventional study evaluates the effects of real-time (open) versus blinded continuous glucose monitoring (CGM) on glycemic variability, lifestyle behaviors, and metabolic outcomes in adults with prediabetes and overweight or obesity (BMI ≥ 27 kg/m²). Thirty participants will undergo both open and blinded CGM phases, separated by a washout period. The study aims to assess whether access to real-time glucose data promotes behavioral change and improves metabolic health compared with blinded CGM use.

This description comes directly from the study's public registry record.

Talk to the study team

Ajda Urbas, medical doctor  ·  0038631626966  ·  ajda.urbas@gmail.com

Always discuss trial participation with your own doctor first.

Locations (3)

University of Primorska, Faculty of Health SciencesIzola, SloveniaRecruiting
Diabetes Outpatient Clinic, Community Health Center Koper, SloveniaKoper, SloveniaRecruiting
Department Of endocrinology and diabetes, Medical Faculty, University of LjubljanaLjubljana, SloveniaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07423065